An Overview of Global Neurosurgery Research in the United States: Identifying Gaps and Potential Areas for Growth

• by Tirone Young, Sophie Epstein, Mehek Dedhia, Rahul Raj, Olufisayo Atanda-Ogunleye, Isabelle M. Germano

• March 24, 2026

Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET)

• by Stefanie Brehmer, Gustavo R. Sarria, Sara Würfel, Ardita Sulejmani, Frank Schneider, Sven Clausen, Yasser Abo-Madyan, Arne M. Ruder, Elena Sperk, Nima Etminan, Frank A. Giordano

• May 28, 2026

Salvage microsurgery for vestibular schwannoma after failed stereotactic radiosurgery: a multi-institutional retrospective study

• by Filippo Friso, Noa Ben Dor, Alfredo Conti, Alfredo Decio Fabbri, Federico Calvaruso, Virginia Dallari, Francesca De Cecco, Franco Federico Bochicchio, Emanuele La Corte, Tomasz Wojciechowski, Kazimierz Niemczyk, Adrian Drożdż, Grzegorz Turek, Lukas Anschuetz, Davide Soloperto, Giacomo Pavesi, Barbara Masotto, Daniele Marchioni, Carmelo Sturiale, Paolo Ferroli, Francesco DiMeco, Livio Presutti, Giulia Molinari

• May 20, 2026

FDA approves FET-PET agent for glioma

The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.

• by Kathryn Wighton

• September 14, 2026

• 2 min